leadf
logo-loader
viewMRG Metals

MRG Metals raises funds for expanded drilling at Corridor Heavy Mineral Sands Projects

The funds raised through share placement will allow the company to expand exploration activities including infill drilling at various projects in Mozambique.

MRG Metals - MRG Metals raises funds for expanded drilling at Corridor Heavy Mineral Sands Projects
Initial drill testing of further new targets including Zulene planned

MRG Metals Ltd (ASX:MRQ) has raised $660,000 via the placement of shares to expand its ongoing exploration activities including the recently started aircore drilling programs at the Corridor Heavy Mineral Sands (HMS) Projects in Mozambique.

The company has raised the fund through the placement of 110 million shares at six cents per share to sophisticated and professional investors.

Following the placement, the drilling, together with associated mineral assemblage analysis will now include the initial drill testing of further new targets, including Zulene.

The funds raised also provides a capacity to start infill or extension drilling to establish a new high-grade JORC Mineral Resource at the Corridor South Project.

“Aggressively extend exploration activities”

MRG chairman Andrew Van Der Zwan said: “We are pleased to have received such strong support to fund our extended exploration program at the Corridor Projects where recent work including the recent mineral assemblage work is demonstrating the significant potential of several of our existing prospects whilst identifying further new targets. 

“Through this Placement, MRG now has the financial flexibility to aggressively extend exploration activities across its HMS project suite in Mozambique and we would like to thank investors, both new and existing, for their support.” 

Quick facts: MRG Metals

Price: 0.007 AUD

ASX:MRQ
Market: ASX
Market Cap: $9.45 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Orthocell 'in exciting regulatory phase' as it looks to drive its...

Orthocell Ltd's (ASX:OCC) Paul Anderson says the company's in an exciting regulatory phase having validated its technologies in the clinic and defining pathways to market through the US FDA process. ''We have some significant milestones ahead of us - we have an application within the FDA at the...

2 hours, 9 minutes ago

2 min read